Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn’s Disease

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

(2020) Xavier Roblin et al.   GUT

New role for azathioprine in case of switching anti-TNFs in IBD

(2020) Konstantinos Papamichael et al.   GUT

Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening

(2020) Ting Zhang et al.   Protein & Cell

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

(2020) Harry Sokol et al.   Microbiome

Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment?

(2020) Liyuan Xiang et al.   Microbial Biotechnology

Biologicals are the main contributor to cost of care for IBD: a European perspective

(2020) Christian P Selinger   Lancet Gastroenterology & Hepatology

Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis

(2020) Qianqian Li et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes

(2020) Qianqian Li et al.   Clinical and Translational Gastroenterology

Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn’s Disease

(2020) Lingjia Kong et al.   GASTROENTEROLOGY

Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation

(2019) Cheuk Yin Lai et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Role of Fecal Microbiota Transplantation for Maintenance of Remission in Patients with Ulcerative Colitis: A Pilot Study

(2019) Ajit Sood et al.   Journal of Crohns & Colitis

Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis

(2019) Xiao Ding et al.   DRUG SAFETY

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

(2019) María José Casanova et al.   INFLAMMATORY BOWEL DISEASES

A novel quick transendoscopic enteral tubing in mid-gut: technique and training with video

(2018) Chuyan Long et al.   BMC GASTROENTEROLOGY

Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?

(2018) Xavier Roblin et al.   INFLAMMATORY BOWEL DISEASES

Microbiota transplantation: concept, methodology and strategy for its modernization

(2018) Faming Zhang et al.   Protein & Cell

Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis

(2018) Gianluca Ianiro et al.   United European Gastroenterology Journal

The Safety of Fecal Microbiota Transplantation for Crohn’s Disease: Findings from A Long-Term Study

(2018) Honggang Wang et al.   ADVANCES IN THERAPY

Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease

(2018) Danning Ma et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn’s disease

(2018) Pan Li et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease

(2017) Sine Buhl et al.   INFLAMMATORY BOWEL DISEASES

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations

(2016) Paolo Gionchetti et al.   Journal of Crohns & Colitis

Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD

(2015) Konstantinos Papamichael et al.   INFLAMMATORY BOWEL DISEASES

Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohnʼs Disease

(2015) David L. Suskind et al.   INFLAMMATORY BOWEL DISEASES

Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis

(2015) Bota Cui et al.   Journal of Translational Medicine

Living with Inflammatory Bowel Disease: A Crohn’s and Colitis Canada Survey

(2015) Helen M Becker et al.   Canadian Journal of Gastroenterology and Hepatology

Benefit of Infliximab Reintroduction after Successive Failure of Infliximab and Adalimumab in Crohn's Disease

(2014) C. Gagniere et al.   Journal of Crohns & Colitis

Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results

(2014) Bota Cui et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

(2013) Jonathan P. Terdiman et al.   GASTROENTEROLOGY

Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review

(2011) Vincent Billioud et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort

(2010) Kelvin T. Thia et al.   GASTROENTEROLOGY

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

(2010) Matthieu Allez et al.   Journal of Crohns & Colitis

Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice

(2009) Y. ZABANA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review

(2009) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY